Overview

Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Temporomandibular Joint Disorders (TMJD).

Status:
Completed

Trial end date:
2016-12-01

Target enrollment:

Participant gender:

Summary

The objetive of this study is to explore the efficacy and safety of a triple combination of ibuprofen, magnesium and ascorbic acid for acute pain treatment in TMJD patients

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Spherium Biomed

Collaborators:

Hospital Odontològic UB
Hospital Universitario La Fe
Hospital Universitario Rey Juan Carlos
Universitat Internacional de Catalunya

Treatments:

Ascorbic Acid
Ibuprofen